NUWENasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Nuwellis, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.56+0.01 (+1.68%)
Close on Oct 19, 2026
- Market cap
- $101.13K
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$119.8480 (−99.54%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsSplit
Nuwellis, Inc. grew revenue 8.4% to $9.01M over the twelve months to Jun 30, 2026. Free cash flow was -$12.59M.
Revenue
$9.01M
+8.4% vs. a year earlier
Operating income
-$12.88M
TTM Q2 2026
Free cash flow
-$12.59M
TTM Q2 2026
EPS, diluted
-$888.65
FY2025
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $101.13K
- P/E ratio
- –
- Price to sales
- 0.01
- Price to book
- –
- Dividend yield
- –
- Free cash flow yield
- -12447.89%
Fundamentals
- Revenue
- $9.01M
- Net income
- -$11.32M
- EPS, diluted
- -$888.65
- Free cash flow
- -$12.59M
- Book value per share
- -$11.34
- Diluted shares
- 0M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$9.01M+8.4% YoY
Gross profit
$6.28M+24.7% YoY
Operating income
-$12.88M
Net income
-$11.32M
EPS, diluted
–
Free cash flow
-$12.59M
Reported periodTrailing twelve months